Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Read More…
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryLife Sciences Tools & Services
SectorComputer and Technology
Phone408-345-8886
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.91 billion
Profitability
Miscellaneous
Employees14,800
Next Earnings Date11/18/2019 (Estimated)
OptionableOptionable
Agilent Technologies (NYSE:A) Frequently Asked Questions
What is Agilent Technologies' stock symbol?
Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."
How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?
Agilent Technologies declared a quarterly dividend on Thursday, September 19th. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.164 per share on Wednesday, October 23rd. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, September 30th. View Agilent Technologies' Dividend History.
How will Agilent Technologies' stock buyback program work?
Agilent Technologies declared that its Board of Directors has approved a share repurchase plan on Monday, November 19th 2018, which allows the company to repurchase $1,750,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 8.8% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's management believes its shares are undervalued.
How were Agilent Technologies' earnings last quarter?
Agilent Technologies Inc (NYSE:A) released its quarterly earnings data on Wednesday, August, 14th. The medical research company reported $0.76 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.72 by $0.04. The medical research company had revenue of $1.27 billion for the quarter, compared to analysts' expectations of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. The company's quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.67 earnings per share. View Agilent Technologies' Earnings History.
When is Agilent Technologies' next earnings date?
What guidance has Agilent Technologies issued on next quarter's earnings?
Agilent Technologies issued an update on its FY19 earnings guidance on Wednesday, August, 14th. The company provided EPS guidance of $3.07-$3.09 for the period, compared to the Thomson Reuters consensus estimate of $3.05. The company issued revenue guidance of $5.105-$5.125 billion, compared to the consensus revenue estimate of $5.11 billion.
What price target have analysts set for A?
13 Wall Street analysts have issued 1 year target prices for Agilent Technologies' stock. Their forecasts range from $76.00 to $92.00. On average, they anticipate Agilent Technologies' stock price to reach $85.73 in the next twelve months. This suggests a possible upside of 13.7% from the stock's current price. View Analyst Price Targets for Agilent Technologies.
What is the consensus analysts' recommendation for Agilent Technologies?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.
What are Wall Street analysts saying about Agilent Technologies stock?
Here are some recent quotes from research analysts about Agilent Technologies stock:
- 1. According to Zacks Investment Research, "Agilent reported strong fiscal third-quarter results on broad-based growth in all its product lines. The company also raised its guidance for full year 2019. The company’s expanding product portfolio, end-market strength and robust performance in Americas, China and Europe are key growth drivers. Moreover, the company’s decision to divest/wind up underperforming businesses is beneficial for its core operations. Further, the company’s focus on aligning investments towards more attractive growth avenues and innovative high-margin product launches are positive. Notably, shares of Agilent have outperformed the industry it belongs to over a year. However, macro weakness in some regions, higher expenses and unfavorable foreign exchange remain concerns." (8/19/2019)
- 2. Barclays PLC analysts commented, "We think Agilent delivered a solid FY1Q19 print last night, featuring a modest top line beat which was leveraged into a 6% EPS beat ($0.76 vs. our $0.72 forecast). Consistent trends help improve our conviction in the thesis heading into FY2019. Organic growth of 6% in the quarter came in 1.2% better than our expectations and guidance. Growth was solid, although less broad-based than last quarter – which we view as understandable in the context of tough quarterly comps. Notably, DGG posted 13% organic growth while ACG delivered 10% organic growth. The capital equipment driven LSAG division posted just" 1% organic growth, but on an 11% quarterly comp. From an end market perspective, we think results hit the mark across customer classes and geographies. Pharma & Sales) posted 10% core growth." (2/21/2019)
Has Agilent Technologies been receiving favorable news coverage?
Media coverage about A stock has been trending somewhat negative on Thursday, according to InfoTrie Sentiment. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Agilent Technologies earned a daily sentiment score of -1.4 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Agilent Technologies.
Are investors shorting Agilent Technologies?
Agilent Technologies saw a decline in short interest during the month of September. As of September 15th, there was short interest totalling 5,990,000 shares, a decline of 10.3% from the August 15th total of 6,680,000 shares. Based on an average daily volume of 2,640,000 shares, the short-interest ratio is currently 2.3 days. Approximately 2.0% of the shares of the company are sold short. View Agilent Technologies' Current Options Chain.
Who are some of Agilent Technologies' key competitors?
Some companies that are related to Agilent Technologies include Illumina (ILMN), Mettler-Toledo International (MTD), Waters (WAT), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), PerkinElmer (PKI), Avantor (AVTR), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Eyepoint Pharmaceuticals (EYPT).
What other stocks do shareholders of Agilent Technologies own?
Who are Agilent Technologies' key executives?
Agilent Technologies' management team includes the folowing people:
- Mr. Michael R. McMullen, CEO, Pres & Director (Age 58)
- Mr. Robert W. McMahon, Sr. VP & CFO (Age 50)
- Mr. Dominique P. Grau, Sr. VP of HR (Age 60)
- Mr. Mark Doak, Sr. VP (Age 64)
- Mr. Jacob Thaysen, Sr. VP (Age 44)
Who are Agilent Technologies' major shareholders?
Agilent Technologies' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.18%), Commerzbank Aktiengesellschaft FI (0.06%), Envestnet Asset Management Inc. (0.05%), Robeco Institutional Asset Management B.V. (0.04%), State of Alaska Department of Revenue (0.04%) and Nisa Investment Advisors LLC (0.03%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael Tang, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.
Which major investors are selling Agilent Technologies stock?
A stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., Meeder Asset Management Inc., Gateway Investment Advisers LLC, Hexavest Inc., Nisa Investment Advisors LLC, Baldwin Brothers Inc. MA, Fulton Bank N.A. and Crossmark Global Holdings Inc.. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.
Which major investors are buying Agilent Technologies stock?
A stock was acquired by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD., Commerzbank Aktiengesellschaft FI, State of Alaska Department of Revenue, Ferguson Wellman Capital Management Inc., TIAA FSB, Occidental Asset Management LLC, Fox Run Management L.L.C. and Northstar Investment Advisors LLC. View Insider Buying and Selling for Agilent Technologies.
How do I buy shares of Agilent Technologies?
Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Agilent Technologies' stock price today?
One share of A stock can currently be purchased for approximately $75.40.
How big of a company is Agilent Technologies?
Agilent Technologies has a market capitalization of $23.33 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 14,800 workers across the globe.View Additional Information About Agilent Technologies.
What is Agilent Technologies' official website?
How can I contact Agilent Technologies?
Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]
MarketBeat Community Rating for Agilent Technologies (NYSE A)
MarketBeat's community ratings are surveys of what our community members think about Agilent Technologies and other stocks. Vote "Outperform" if you believe A will outperform the S&P 500 over the long term. Vote "Underperform" if you believe A will underperform the S&P 500 over the long term. You may vote once every thirty days.
